Corrigendum: Baseline neutrophils and derived neutrophilto-lymphocyte ratio: Prognostic relevance in metastatic melanoma patients receiving ipilimumab. [Ann Oncol 27, (2016), (732-738)] doi:10.1093/annonc/mdw016.

P. F. Ferrucci, P. A. Ascierto, J. Pigozzo, M. Del Vecchio, M. Maio, G. C.Antonini Cappellini, M. Guidoboni, P. Queirolo, P. Savoia, M. Mandalà, E. Simeone, S. Valpione, M. Altomonte, F. Spagnolo, E. Cocorocchio, S. Gandini, D. Giannarelli, C. Martinoli

Research output: Contribution to journalComment/debatepeer-review

Abstract

Ann Oncol 2016; 27: 732-738 (doi:10.1093/annonc/mdw016) There is an error in the affiliation of author Jacopo Pigozzo. The correct affiliation is 'Melanoma and Esophageal Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy'.

Original languageEnglish
Number of pages1
JournalAnnals of Oncology
Volume29
Issue number2
DOIs
Publication statusPublished - Apr 1 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Corrigendum: Baseline neutrophils and derived neutrophilto-lymphocyte ratio: Prognostic relevance in metastatic melanoma patients receiving ipilimumab. [Ann Oncol 27, (2016), (732-738)] doi:10.1093/annonc/mdw016.'. Together they form a unique fingerprint.

Cite this